← Back to Search

Telemental Health for Suicidal Thoughts

N/A
Waitlist Available
Led By Justin C Baker, PhD
Research Sponsored by Ohio State University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
18 years of age or older
18 years of age or older;
Must not have
Impaired mental status that precludes the ability to provide informed consent (e.g., intoxication, psychosis, mania)
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline, 3, 6, 9, and 12 month follow-up.
Awards & highlights
No Placebo-Only Group

Summary

This trial will compare the effectiveness of two therapies, one of which has been shown to be effective in the past, for reducing suicidal thoughts and behaviors. The therapies will be delivered via telehealth.

Who is the study for?
This trial is for adults over 18 who have suicidal thoughts or attempted suicide recently. Participants must speak English, own a device like a smartphone with internet access, and be able to consent. People can't join if they're unable to consent due to mental status issues, need immediate hospitalization for suicide risk, or have an acute substance use disorder.
What is being tested?
The study compares two types of therapy delivered via telehealth: Brief Cognitive Behavioral Therapy (BCBT) aimed at preventing suicide and Present-Centered Therapy (PCT), which serves as an active comparison treatment. The goal is to see if BCBT reduces suicidal thoughts and behaviors more effectively when done remotely.
What are the potential side effects?
Since this trial involves psychological therapies conducted through telehealth services rather than medication, traditional side effects are not expected. However, participants may experience emotional discomfort discussing sensitive topics during therapy sessions.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am 18 years old or older.
Select...
I am 18 years old or older.

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:
Select...
I am mentally capable of understanding and consenting to treatment.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline, 3, 6, 9, and 12 month follow-up.
This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline, 3, 6, 9, and 12 month follow-up. for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Change in number of suicide attempts from baseline.
Feeling suicidal (finding)
Secondary study objectives
Change in psychiatric symptom severity will be measured across multiple time points post-treatment.

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Brief Cognitive Behavioral Therapy (BCBT)Experimental Treatment1 Intervention
Group II: Present-Centered Therapy (PCT)Active Control1 Intervention
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Brief Cognitive Behavioral Therapy (BCBT)
2011
N/A
~340

Find a Location

Who is running the clinical trial?

Ohio State UniversityLead Sponsor
871 Previous Clinical Trials
655,572 Total Patients Enrolled
Justin C Baker, PhDPrincipal InvestigatorOhio State University

Media Library

Brief Cognitive Behavioral Therapy (BCBT) Clinical Trial Eligibility Overview. Trial Name: NCT04844294 — N/A
Suicidal Thoughts Research Study Groups: Brief Cognitive Behavioral Therapy (BCBT), Present-Centered Therapy (PCT)
Suicidal Thoughts Clinical Trial 2023: Brief Cognitive Behavioral Therapy (BCBT) Highlights & Side Effects. Trial Name: NCT04844294 — N/A
Brief Cognitive Behavioral Therapy (BCBT) 2023 Treatment Timeline for Medical Study. Trial Name: NCT04844294 — N/A
~34 spots leftby Dec 2025